Stage IIA Prostate Cancer Completed Phase 2 Trials for Broxuridine (DB12028)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003832Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate CancerTreatment